LakeShore Biopharma Co., Ltd. Quarterly Liabilities in CNY from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: CNY and USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
LakeShore Biopharma Co., Ltd. quarterly Liabilities history and growth rate from Q1 2022 to Q1 2024.
  • LakeShore Biopharma Co., Ltd. Liabilities for the quarter ending March 31, 2024 was ¥928M, a 6.4% decline year-over-year.
Liabilities, Quarterly (CNY)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 928M -63.5M -6.4% Mar 31, 2024 20-F 2024-08-15
Q1 2023 991M +221M +28.7% Mar 31, 2023 20-F 2024-08-15
Q1 2022 771M Mar 31, 2022 20-F 2023-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.